Telmisartan and Baraclude drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Telmisartan (telmisartan) and Baraclude (entecavir). Common drug interactions include adrenal insufficiency among males.

The phase IV clinical study analyzes what interactions people have when they take Telmisartan and Baraclude. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Telmisartan?

Telmisartan has active ingredients of telmisartan. It is often used in high blood pressure. eHealthMe is studying from 9,163 Telmisartan users. Check the latest studies of Telmisartan.

What is Baraclude?

Baraclude has active ingredients of entecavir. It is often used in hepatitis b. eHealthMe is studying from 6,175 Baraclude users. Check the latest studies of Baraclude.

On Jul, 29, 2026

19 people who take Telmisartan and Baraclude together, and have interactions are studied.

Telmisartan and Baraclude drug interactions.

What are the common drug interactions of Telmisartan and Baraclude, by gender? *:

female:

n/a

male:

Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
Bradycardia (abnormally slow heart action)
Hepatic failure (liver failure)
Blood creatine phosphokinase increased
Blood lactate dehydrogenase increased
C-reactive protein increased
Excoriation (to tear or wear off the skin of)
Fall
Hepatic enzyme increased
Muscle enzyme increased

What are the common drug interactions of Telmisartan and Baraclude, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Myopathy (a muscular disease in which the muscle fibres do not function)
Hepatic failure (liver failure)
Blood creatine phosphokinase increased
Blood lactate dehydrogenase increased
C-reactive protein increased
Excoriation (to tear or wear off the skin of)
Fall
Hepatic enzyme increased
Muscle enzyme increased
Muscular weakness (muscle weakness)

50-59:

Putamen haemorrhage (bleeding in outer part of the lentiform nucleus of the brain)

60+:

Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
Bradycardia (abnormally slow heart action)
Depressed level of consciousness
Enteritis infectious (infection with feline parvovirus (fpv), also known as feline panleucopenia virus)
Pneumonia
Pyrexia (fever)
Respiratory arrest (cessation of normal respiration due to failure of the lungs to function effectively)
Sepsis (a severe blood infection that can lead to organ failure and death)

What are the existing conditions these people have? *

Palmar-Plantar Erythrodysaesthesia Syndrome (hand-foot syndrome): 14 people, 73.68%
Nausea (feeling of having an urge to vomit): 14 people, 73.68%
Hepatic Neoplasm Malignant (liver cancer): 14 people, 73.68%
Gastric Ulcer (stomach ulcer): 14 people, 73.68%
Diarrhea: 14 people, 73.68%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 11 people, 57.89%
Excoriation (to tear or wear off the skin of): 7 people, 36.84%
Non-Small Cell Lung Cancer Recurrent (type of epithelial lung cancer reoccurrence): 4 people, 21.05%
Hyperkalemia (damage to or disease of the kidney): 1 person, 5.26%
Hepatocellular Carcinoma (liver cancer): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Telmisartan and Baraclude?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously